Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00637754
Other study ID # 0608001730
Secondary ID
Status Completed
Phase N/A
First received March 11, 2008
Last updated June 10, 2015
Start date September 2006
Est. completion date January 2015

Study information

Verified date June 2015
Source Yale University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

The registry will obtain information to determine the safety of sports participation for patients with defibrillators (ICDs).


Description:

Patients who are participating in sports who have defibrillators will be invited to participate in a prospective registry to determine the rate of adverse events occurring during sporting activities. Patients will be followed for four years and adverse events quantified. Yale is the coordinating center for this multicenter registry.


Recruitment information / eligibility

Status Completed
Enrollment 400
Est. completion date January 2015
Est. primary completion date January 2015
Accepts healthy volunteers No
Gender Both
Age group 10 Years to 60 Years
Eligibility Inclusion Criteria:

- individuals between the ages of 10 and 60

- has a defibrillator

- plays a competitive/organized sport more vigorous than golf or bowling or participates in a dangerous sport

Exclusion Criteria:

- children under 10 years (as they engage in primarily recreational sports)

- individuals over the age of 60 years (maintain a homogenous population)

- inability to give informed consent

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Australia St. Vincent's Hospital, Mebourne LTD Fitzroy Victoria
Belgium OLV Hospital Aalst Aalst
Belgium Clin.du sud-Luxembourg Arlon
Belgium UZ Antwerpen Edegem
Belgium UZ Leuven Leuven
Canada London Health Sciences Centre University Hospital London Ontario
Canada Institut de Cardiologie de Montreal Montreal Quebec
Canada The University of British Columbia Vancouver British Columbia
Czech Republic IKEM Praha 4
France CHRU-Hopital de Pontchaillou Rennes
France Dlinique Pasteur Toulouse
Germany Univeristy of Leipzig Heart Centre Leipzig
Germany Klinikum Bogenhausen Munchen
Israel Tel Aviv Sourasky Medical Center Tel Aviv
Netherlands Radboud University Hospital Nijmegen Nijmegen
Netherlands Erasmus Medisch Centrum Rotterdam
Norway Rikshospitalet Oslo Oslo
Poland Sterling Memorial University Hospital Lodz
Spain Hospital Clinic-University of Barcelona Barcelona
Spain Hospital Puerta de Hierro Majadahonda
Switzerland University of Bern Bern
Switzerland University Hospital Zurich Zurich
United Kingdom Southampton General Hospital Hants
United States Michigan Heart, PC Ann Arbor Michigan
United States Children's Healthcare of Atlanta Atlanta Georgia
United States Children's Hospital Boston Boston Massachusetts
United States Tufts-New England Medical Center Boston Massachusetts
United States Medical University of South Carolina Charleston South Carolina
United States Johns Hopkins University Chicago Illinois
United States The Cleveland Clinic Foundation Cleveland Ohio
United States The Ohio State University Research Foundation Columbus Ohio
United States Duke University Durham North Carolina
United States University of Iowa Iowa City Iowa
United States Heart Clinic Arkansas Little Rock Arkansas
United States Foundation for the Advancement of Cardiovascular Therapy Los Angeles California
United States University of Southern California Los Angeles California
United States Medical College of Wisconsin Milwaukee Wisconsin
United States Minneapolis Heart Institute Foundation Minneapolis Minnesota
United States Park Nicollet Minneapolis Minnesota
United States Arrhythmia Center of Connecticut New Haven Connecticut
United States Arizona Pediatric Cardiology Consultants Phoenix Arizona
United States Legacy Cllinical Research & Tech Center (Good Samaritan Hospital_ Portland Oregon
United States Children's Hospital and Clinics of Minnesota Roseville Minnesota
United States University of Utah Salt Lake City Utah
United States University of California, San Francisco San Francisco California
United States University of Washington Seattle Washington
United States Washington University St. Louis Missouri
United States Midatlantic Cardiovascular Associates, PA Towson Maryland
United States University of Arizona Tucson Arizona
United States Children's National Medical Center Washington District of Columbia
United States George Washington University Washington District of Columbia
United States Walter Reed Army Medical Center Washington District of Columbia
United States Cypress Heart Wichita Kansas
United States Main Line Health Heart Center Wynnewood Pennsylvania

Sponsors (4)

Lead Sponsor Collaborator
Yale University Boston Scientific Corporation, Medtronic, St. Jude Medical

Countries where clinical trial is conducted

United States,  Australia,  Belgium,  Canada,  Czech Republic,  France,  Germany,  Israel,  Netherlands,  Norway,  Poland,  Spain,  Switzerland,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Resuscitated arrest or death during sports, or injury during sports due to arrhythmic symptoms and/or shock. four years Yes
Secondary System malfunction and incidence of ventricular arrhythmias (VA) requiring multiple shocks for termination four years. Yes

External Links